PAPPA and Down syndrome: However, as non-invasive prenatal testing (NIPT) with high sensitivity and low false positive rate for the detection of Down syndrome was indicated mainly in high-risk pregnant women including women aged 35 years or more [31], NIPT has been widely used as an initial fetal aneuploidy screening test rather than a maternal serum screening including PAPP-A [32] in those women.